Best GLP-1 Providers in Tennessee (2026)

See by medication

Looking for a specific GLP-1? Browse Tennessee providers by drug.

About GLP-1s in Tennessee

Tennessee allows telehealth GLP-1 prescriptions. Tennessee Medicaid (TennCare) covers GLP-1s only for type 2 diabetes.

• •Tennessee's adult obesity rate is 36.4%, in the top 10 nationally
• •TennCare restricts GLP-1 coverage to diabetes
• •Nashville is a growing Southeast telehealth market

Top Cities for GLP-1 Treatment in Tennessee

Telehealth providers ship to all Tennessee addresses, but demand is highest in these metro areas:

Prefer an in-person clinic? Browse the Tennessee GLP-1 clinic directory →

GLP-1 Care Access in Tennessee: The Numbers

Tennessee has 501 NPI-registered in-person weight-management clinics across 85 cities — 8 with an obesity-medicine taxonomy, 215 endocrinology, and 286 bariatric — alongside 97 telehealth programs that ship to Tennessee addresses. The cheapest verified ongoing compounded semaglutide price available to Tennessee residents is $79/mo (tirzepatide: $97/mo). Full methodology and the 50-state table: GLP-1 care access by state.

Insurance & Medicaid in Tennessee

In Q1 2026, Tennessee Medicaid reimbursed approximately $70,654,042 across 62,722 GLP-1 prescriptions (all covered indications, gross before rebates — federal SDUD data; full state series here).

Most insurance plans in Tennessee cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), but coverage for obesity-only indications (Wegovy, Zepbound) is much more limited and often requires prior authorization. If your insurance won't cover brand-name GLP-1s, compounded semaglutide through telehealth is typically the most affordable option at around $189/mo.

For the exact criteria, drug list, and appeal process, read our Tennessee Medicaid GLP-1 coverage & prior-authorization guide. For coverage backdoors, Zepbound is FDA-approved for obstructive sleep apnea, and Wegovy for kidney and cardiovascular indications, which some plans cover even when they exclude weight-loss-only use.

Obesity in Tennessee

According to CDC data, 36.4% of Tennessee adults have obesity (BMI of 30 or higher). This places Tennessee at #9 out of 50 states. Access to GLP-1 medications like semaglutide and tirzepatide has expanded significantly through telehealth, helping Tennessee residents get clinically supervised weight loss treatment from home.

To choose a medication, compare the clinical-trial results behind each drug, see our best semaglutide and tirzepatide provider rankings, or track the next-generation GLP-1 pipeline.

Frequently Asked Questions